Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Reminder: Changes to precertification requirements for 2017

January 6, 2017

[

As of January 1, 2017, new precertification requirements apply to our commercial and Medicare Advantage HMO and PPO members for the following service and drugs eligible for coverage under the medical benefit.

Service

As of January 1, 2017, insulin pumps require precertification approval from Independence.

Drugs

As of January 1, 2017, the drugs listed below require precertification approval from Independence:

  • Cinqair® (reslizumab)
  • Cubicin® (daptomycin)
  • DarzalexTM (daratumumab)
  • Erwinaze® (L-asparaginase)
  • Exondys 51TM (eteplirsen)
  • Faslodex® (fulvestrant)
  • Hymovis® (high molecular weight viscoelastic hyaluronan)
  • InflectraTM (infliximab)*
  • Neulasta® (pegfilgrastim)*
  • Neulasta® (pegfilgrastim) Onpro®*
  • Sandostatin® LAR (octreotide acetate)
  • TecentriqTM (atezolizumab)

In addition, the following drugs are currently pending approval from the U.S. Food and Drug Administration (FDA). Once they receive FDA approval, they will also require precertification approval from Independence:

  • Cingal® (sodium hyaluronate/triamcinolone hexacetonide)
  • OcrevusTM (ocrelizumab)
  • Remune® (HIV-1 immunogen)

These changes are reflected in an updated precertification requirement list, which is posted to our website.

*Precertification requirements apply to all biosimilars of infliximab and pegfilgrastim approved by the FDA.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.